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ABSTRACT 
Background: Blood glucose and insulin are elevated after intake of carbohydrate, with levels 
returning to normal in about 2-3 hours after ingestion. We examined the effects of daily New 
Zealand blackcurrant intake over 7 days on fasting glucose and insulin levels and the responses of 
glucose and insulin during an oral glucose tolerance test (i.e. OGTT).  
 
Methods: Seventeen healthy participants (9 males, 8 females, age: 24±8 years, body mass: 
75.4±16.4 kg, height 172±11 cm, body mass index: 25.3±3.3) consumed 6 g·day-1 New Zealand 
blackcurrant (NZBC) powder for 7 days. Every 6 g of the serving contained 138.6 mg 
anthocyanins, 49 mg vitamin C, and 5.2 g of carbohydrates with total phenolic content 271.6 mg. 
A cross-over design was used. Participants completed one OGTT before starting the 
supplementation (day 0) and another OGTT after 7 days of the supplementation (day 7). For the 
OGTT, participants were seated and consumed 75 g of glucose dissolved in 250 mL water. Finger 
prick capillary samples were taken before and every 30 minutes for a total of 120 minutes after 
consuming the glucose drink. Following duplicate glucose analysis, blood samples were 
centrifuged and then plasma was separated and frozen (-20°C) for triplicate insulin analysis using 
a human 96-well insulin enzyme-linked immunosorbent assay (IBL international, Hamburg, 
Germany).  
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Results: NZBC had no effect on fasting glucose (control: 4.46±0.45; NZBC: 4.41±0.44 mmol·L1, 
P=0.657), although there was a trend for fasting insulin to be 14.3% lower (control: 66.5±28.2; 
NZBC: 57.0±29.5 pmol·L-1) (P=0.091). HOMA-IR was not different between the control and 
NZBC (1.81±0.73 vs 1.58±0.83) (P=0.126). With NZBC during the OGTT, plasma glucose at 60 
min was 8.1% lower (control: 6.68±1.13; NZBC: 6.14±1.41 mmol·L-1; P=0.016), insulin at 30 min 
was 18.4% lower (control: 337.1±228.3; NZBC: 275.0±136.4 pmol·L-1; P= 0.021), and insulin at 
60 min was 39.2% lower (control: 297.8±154.3; NZBC: 181.2±97.4 pmol·L-1; P= 0.002). With 
NZBC during the OGTTs, areas-under-the-curve for plasma glucose (control: 752.6±79.4, NZBC: 
709.8±93.3 mmol·L-1·120 min) and insulin (control: 28443±12816, NZBC: 20406±7985, pmol·L-
1·120 min) were 5.7% (P=0.051) and 31.1% lower (P<0.001) respectively. 
 
Conclusion: A trend for lower fasting insulin with normal glucose and lower areas under the curve 
for glucose and insulin suggests that repeated intake of New Zealand blackcurrant powder 
increases insulin sensitivity. This is the first observation of a high-anthocyanin containing berry 
powder to increase insulin sensitivity. Regular intake of New Zealand blackcurrant powder may 
be beneficial for the postprandial responses in people with type 2 diabetes or metabolic syndrome. 
 




Blood glucose and insulin are elevated after consumption of carbohydrate, with levels returning to 
normal about 2-3 hours after ingestion. The acute intake of anthocyanin-rich blackcurrant drinks 
before a high carbohydrate meal reduced postprandial glucose and insulin levels [1]. Nutritional 
intervention studies on the acute effects of the intake of blackcurrant drinks do not provide 
information on potential adaptations with repeated intake (e.g. 7 days). In a cross-sectional study 
in females (n=1997), the repeated intake of one of the main anthocyanins in blackcurrant (i.e. 
delphinidin) was associated with lower fasting insulin levels [2]. Additionally, a higher 
consumption of anthocyanins was associated with a lower risk for type 2 diabetes [3]. However, 
the effects of repeated intake of blackcurrant powder on fasting glucose and insulin levels and 
postprandial glucose and insulin responses are unknown. 
Postprandial blood glucose typically results in a peak value in the first 60 min with levels 
returning to normal in about 2 hours [1, 4]. It is the result of the digestive and absorption processes 
of food components in the mouth, stomach, and small intestine, in addition to the uptake of blood 
glucose by tissues for storage and as an energy source. Furthermore, a reduced ability to lower 
postprandial blood glucose in the first few hours after a meal with a high carbohydrate content 
may be indicative of a decrease in insulin sensitivity and/or insulin secretion. Abnormal glucose 
clearance may increase the risk for development of type 2 diabetes [5], likely associated with 
attenuation of endothelial relaxation in healthy subjects with a family history of diabetes [6]. 
In addition to the carbohydrate content of the dietary intake, other components may also affect 
the postprandial blood glucose response, with recent evidence indicating a role for the effects of 
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polyphenols [7] and more specifically anthocyanins [8]. Blackcurrant is high in content of the 
polyphenol anthocyanin [9, 10]. Blackcurrant components inhibit salivary and pancreatic α-
amylase and intestinal α-glucosidase activity in vitro [11, 12, 13, 14]. The inhibition of α-amylase 
and α-glucosidase are causally linked with blunting of the in vivo postprandial blood glucose 
response following the intake of polyphenol and fibre-rich fruits and green tea [15]. Additionally, 
an anthocyanin-rich berry extract containing the anthocyanins present in blackcurrant (i.e. 
delphinidin and cyanidin) decreased acute glucose transport in human intestinal Caco-cells with 
16 h exposure decreasing the expression of both sodium-dependent glucose transporter (i.e. 
SGLT1) mRNA and glucose transport 2 (i.e. GLUT-2) mRNA [16]. Therefore, in vitro studies 
provide observations that seem to indicate that anthocyanins can affect carbohydrate digestion and 
absorption in vivo. Recently, postprandial glucose and insulin responses were examined in an in 
vivo study with a group of men and postmenopausal women after the acute intake of a non-sugar 
added fruit drink with different doses of blackcurrant extract [1]. It was observed that the dose of 
599 mg of blackcurrant anthocyanins reduced blood glucose in the first 30 min postprandial 
compared with no effect of an intake of 131 mg and 322 mg of anthocyanins [1]. To our 
knowledge, this was the first study with in vivo observations for beneficial effects of blackcurrant 
juice on the postprandial glucose and insulin response. However, nutritional intervention studies 
on the acute effects of the intake of blackcurrant drinks do not provide information on potential 
effects that may occur with repeated intake (e.g. 7 days) on fasting glucose and insulin levels. 
Fasting insulin and glucose levels have been linked with pre-diabetes diagnosis [17, 18]. The effect 
of repeated intake of blackcurrant on fasting glucose and insulin levels and the responses of 
glucose and insulin to carbohydrate intake are unknown.  
The aim of the present study was to examine the effect of repeated intake of New Zealand 
blackcurrant powder on postprandial glucose and insulin in non-diabetic individuals. It was 
hypothesized that the intake of New Zealand blackcurrant powder would enhance insulin 
sensitivity in non-diabetic individuals. This is the first study to provide observations on the effects 




Ethical approval was obtained from the Ethics Committee of the University. Seventeen participants 
(9 males, age: 27±12 years, body mass: 79.3±15.0 kg, height: 177±8 cm, body mass index: 
24.9±2.6 kg·m-2; 8 females, age: 23±2 years, body mass: 69.2±18.1 kg, height: 163±8 cm, body 
mass index: 25.7±4.5 kg·m-2) provided written informed consent. A health history questionnaire 
was completed and confirmed the absence of a pre-diabetic or diabetic state. Participants were 
healthy.  
 
Design, supplementation and measurements 
The study used a cross-over design. Participants visited the laboratory twice after an overnight fast 
for an oral glucose tolerance test (i.e. OGTT) and instructed to have identical dietary intake on the 
day before the OGTT. No placebo was provided for the control condition. Participants were tested 
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first for the control condition. For supplementation, participants were provided with 7 doses of 6 
g of New Zealand blackcurrant (NZBC) powder (Sujon Berries, Nelson, New Zealand) in opaque 
plastic vials. Per 6 g serving, Sujon New Zealand blackcurrant powder contains 138.6 mg 
anthocyanin (total phenolic content 271.6 mg), 49 mg vitamin C, and 5.2 g of carbohydrates. For 
6 days, participants were instructed to take 6 g of NZBC powder dissolved in water around 
breakfast. The 7th dose was taken 1 hr before attending the laboratory for the OGTT. For the OGTT, 
participants were provided with 75 g of glucose dissolved in 250 ml of water. Participants were 
seated for the duration of the OGTT with finger prick capillary blood samples taken at 0, 30, 60, 
90, and 120 min after glucose intake. Blood glucose was measured immediately in duplicates (YSI 
2300 Stat Plus, Yellow Springs Instruments Co. Inc., Yellow Springs, USA). The remaining 
samples were centrifuged (C2 Series, Centurion Scientific, Chichester, UK) at 5000 rpm for 5-
min, providing about 90 µL of plasma. The plasma was pipetted and frozen at -20°C for insulin 
analysis. Plasma insulin samples were measured in triplicate (~25 µL of plasma for each 
measurement) using a human 96-well insulin enzyme-linked immunosorbent assay (IBL 
international, Hamburg, Germany). The insulin assay was based on the sandwich principle with 
the microtiter wells pre-coated with the antibody. The intensity of the colour developed was 
proportional to the concentration of insulin with absorbance values of each well determined at 450 
nm with a microtiter plate reader (Tecan GENios, Männedorf, Switzerland). 
 
Data and statistical analysis 
The area under the curve for insulin and glucose (i.e. AUCinsulin and AUCglucose) were calculated 
using the trapezoid method and expressed as pmol·L-1·120 min and mmol·L-1·120 min 
respectively. Fasting insulin, fasting glucose, HOMA-IR [i.e. homeostatic model assessment of 
insulin resistance, (fasting glucose ∙ fasting insulin)/22.5)], insulin and plasma glucose at either 
30, 60, 90, or 120 min, AUCinsulin, AUCglucose and changes in AUCs for males and females were 
analyzed with paired and unpaired samples student t-tests. Statistical significance was accepted at 
P<0.05. Interpretation of 0.05>P ≤0.1 was according to guidelines by Curran-Everett & Benos 
[19]. Data are presented as mean ± SD unless stated otherwise. Calculations and statistical analysis 




NZBC had no effect on fasting glucose (control: 4.46±0.45; NZBC: 4.41±0.44 mmol·L-1, P=0.66) 
(Figure 1) but there was a trend for fasting insulin to be 14.3% lower (control: 66.5±28.2; NZBC: 
57.0±29.5 pmol·L-1, P=0.091) (Figure 2), with 9 of the 17 participants having lower values. 
HOMA-IR for control and NZBC was 1.81±0.73 and 1.58±0.83 respectively and not different 
(P=0.126). Plasma glucose during the OGTT was 8.1% lower at 60 min with NZBC (control: 
6.68±1.13; NZBC: 6.14±1.41 mmol·L-1; P=0.016) (Figure 1), with 13 participants having lower 
values. Insulin was 18.4% lower at 30 min with NZBC (control: 337.1±228.3; NZBC: 275.0±136.4 
pmol·L-1; P= 0.021), with 11 participants having lower values. Insulin was 39.2% lower at 60 min 
with NZBC (control: 297.8±154.3; NZBC: 181.2±97.4 pmol·L-1; P= 0.002) (Figure 2), with 12 
participants having lower values.  
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Figure 1. Postprandial blood glucose concentrations during the 2 hr oral glucose tolerance 
test. *, indicates difference between control and New Zealand blackcurrant (NZBC) powder at 60 
min (p<0.05). Data are mean±SEM (n=17). 
 
 
Figure 2. Postprandial blood insulin concentrations during the during the 2 hr oral glucose 
tolerance test. #, indicates a trend for a difference between the control and New Zealand 
blackcurrant (NZBC) powder for fasting insulin (P=0.091); *, indicates a difference between the 
control and NZBC powder at 30 and 60 min (P<0.05). Data are mean±SEM (n=17). 
 
With NZBC during the OGTTs, there was a strong trend for lower AUCglucose (control: 
752.6±79.4, NZBC: 709.8±93.3 mmol·L-1·120 min, P=0.051) (Figure 3), with 11 participants 
having lower values. There was no difference between females and males for the change in 
AUCglucose with NZBC (P=0.374). With NZBC during the OGTTs, AUCinsulin was 31.1% lower 
(control: 28443±12816, NZBC: 20406±7985, pmol·L-1·120 min, P<0.001) (Figure 4), with 14 of 
the 17 participants having lower values. Compared to females, there was a trend for males to have 
larger changes in AUCinsulin with NZBC (P=0.093). 
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Figure 3. Postprandial area under the curve (AUC) for blood glucose during the 2 hr oral 
glucose tolerance test. *, indicates a difference between control and New Zealand blackcurrant 
powder (P<0.05). Data are mean±SEM (n=17). 
 
Figure 4. Postprandial area under the curve (AUC) for blood insulin glucose during the 2 hr 
oral glucose tolerance test. *, indicates a difference between control and New Zealand blackcurrant 
powder (P<0.05). Data are mean±SEM (n=17). 
 
DISCUSSION 
The present study provides novel observations in healthy individuals on the effects of a 7-day 
intake of a high anthocyanin-containing berry powder on fasting glucose and insulin, in addition 
to the glucose and insulin responses after high glucose intake (i.e. 75 g). We observed that 7-day 
intake of 6 g of New Zealand blackcurrant powder (i.e. ~138.6 mg of blackcurrant 
anthocyanins/day) tended to reduce fasting insulin by 14.3%, and reduced the area under the curve 
for glucose and insulin during an OGTT by 5.7% and 31.1% respectively. These observations 
suggest an increase in insulin sensitivity occurs through the intake of New Zealand blackcurrant 
powder intake. 
Lower fasting insulin and normal fasting glucose in the present study confirms the 
observations of a cross-sectional study of 1997 females (18-76 years) on the habitual intake of 
polyphenol classes and insulin resistance [2]. It was reported that the habitual intake of the 
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anthocyanins delphinidin, malvinidin, peonidin, and petunidin reduced fasting insulin by 9.4%, 
but only in participants in the highest quintile (total anthocyanin intake of 39.9±15.0 mg∙day-1) 
compared to the lowest quintile [2]. In blackcurrant, the delphinidins (i.e. delphinidin-3-O-
glucoside and delphinidin-3-O-rutinoside) make up 66% of the total blackcurrant anthocyanin 
content [20]. The main anthocyanins in blackcurrant are cyanidin-3-O-glucoside, cyanidin-3-O-
rutinoside, delphinidin-3-O-glucoside, and delphinidin-3-O-rutinoside, which makes up about 
98% of the total anthocyanin content [20]. We cannot exclude that the effects by the intake of all 
blackcurrant anthocyanins (intake 138.6 mg/day) were required to lower fasting insulin in the 
present study. Future studies may want to examine the effects of short-duration intake of other 
berry powders having different polyphenol composition on fasting insulin in healthy individuals. 
Intake of highbush blueberry powder for 90 days in Zucker fatty rats on high-fat and low-fat diets 
lowered fasting insulin with normal fasting glucose [21], while no effect was observed on fasting 
insulin and glucose with a 6 week intake of two smoothies a day containing each 22.5 g of 
blueberry bioactives in obese insulin-resistant men and women [22] and in adults with metabolic 
syndrome [23]. An acute intake of delphinidin-rich maqui berry extract lowered fasting insulin 
and glucose after 60 min in pre-diabetic individuals [24]. In the present study, fasting insulin was 
not measured before the final intake of New Zealand blackcurrant on the day of testing. Therefore, 
we can not exclude that the tendency to have lower fasting insulin in the present study was due to 
the final intake of New Zealand blackcurrant. The final intake of New Zealand blackcurrant 
contained 5.2 g of carbohydrates, an amount that is too small to cause a rise in blood glucose levels. 
Our observations of lower fasting insulin with normal fasting glucose may therefore be indicative 
of increased insulin sensitivity. However, HOMA-IR was not shown to be different with New 
Zealand blackcurrant intake, while 10 out of 17 participants had lower HOMA-IR values, Thus, 
the present study may have been underpowered. 
As far as we know, our observations over a 2 hour period on the reduction of both the area 
under the curve for glucose and insulin during an OGTT by 7-day intake of New Zealand 
blackcurrant powder have not been examined in studies with other berries. Recently, it was 
observed in a study with a group of men and postmenopausal women that the acute intake of 
blackcurrant in a low sugar fruit drink with an anthocyanin content of 599 mg before a high 
carbohydrate meal (39 g starch and 23 gr sucrose) reduced blood glucose and insulin in the first 
30 min postprandial compared to an intake of 131 mg and 322 mg of anthocyanins [1], with no 
changes in area under the curve for blood glucose and insulin over a 2 hour period for any 
anthocyanin content. The absence of a change in area under the curve for glucose and insulin was 
due to a rebound effect with higher glucose at 75 min and higher insulin and 75 and 90 min [1]. A 
rebound effect on glucose and insulin was not observed in the present study. Methodological 
differences between the present study and Castro-Acosta et al [1] with respect to carbohydrate 
intake, dietary restrictions for high polyphenol intake for 24 h, and subject characteristics 
complicates judgement of whether New Zealand blackcurrant powder was more potent for 
postprandial responses. However, the low dose intake of anthocyanins in the Castro-Acosta et al 
study (i.e. 131 mg) with blackcurrant in a fruit drink did not provide any significant findings [1] 
and was comparable with the intake in the present study (i.e. 138 mg). Additionally, in the present 
study, responses were observed after an overnight fast with no dietary restrictions and the glucose 
responses were examined after glucose intake. Therefore, there was no role of enzymes normally 
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involved in the breakdown of various carbohydrates into glucose, i.e. α-amylase and α-
glucosidase. Future studies may want to examine the effect of New Zealand blackcurrant on the 
postprandial glucose and insulin responses after an intake of complex carbohydrates or a normal 
meal. Furthermore, future studies may want to examine sex-differences in insulin responses to 
blackcurrant intake in well powered studies. In the present study, hormonal status in females due 
to menstruation phase and/or intake of oral contraceptives was not considered when tested for the 
OGTT responses. 
It would be of interest to examine the dose effects of chronic intake of New Zealand 
blackcurrant powder on postprandial responses as anthocyanin intake was much higher in Castro-
Acosta et al [1]. We observed dose effects on cardiovascular function in rest with New Zealand 
blackcurrant extract [25]. The lower glucose response may be due to inhibition of intestinal 
absorption by reduced contribution of the active Na+-dependent transport via sodium glucose co-
transporter 1 and facilitated Na+-independent transport via GLUT2 and/or an increase in insulin 
sensitivity. However, Castro-Acosta et al observed lower gastric inhibitory peptide with a high 
dose of blackcurrant intake [1]. Therefore, the lower insulin responses may be due also to an effect 
on gastric inhibitory peptide and/or a direct effect on the pancreatic functioning by intake of New 
Zealand blackcurrant powder. Furthermore, cyanidin-3-O-glucoside lowered postprandial 
hyperglycemia by an effect in part on GLUT-4 translocation in soleus muscle by activation of both 
insulin and AMPK-signalling pathways [26]. Additionally, in vitro studies have shown effects of 
the phenolic metabolites that result from blackcurrant intake on insulin and glucose handling [27]. 
For example, protocatechuic acid mimics insulin activity in visceral adipocytes [28], gallic acid 
induces GLUT4 translocation and glucose uptake activity in 3T3-L1 cells [29], and protocatechuic 
acid derived vanillic acid may ameliorate insulin-resistant insulin resistance in FL83B mouse 
hepatocytes [30]. However, supraphysiological concentrations of phenolic metabolites used in in 
vitro studies warrants caution when extrapolating to in vivo conditions. 
 
CONCLUSIONS 
A 7-day intake of New Zealand blackcurrant powder reduced fasting insulin and lowered glucose 
and insulin responses during an oral glucose tolerance test. Regular intake of New Zealand 
blackcurrant may reduce the risk for development of type II diabetes in healthy individuals. Future 
work should examine the effects of regular intake of New Zealand blackcurrant on postprandial 
responses in people with type II diabetics or metabolic syndrome. 
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